Nasdaq:US$17.59 (+0.07) | HKEX:HK$27.90 (+0.40) | AIM:£2.58 (+0.06)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702